- Home
- LXRX vs THW Comparison
LXRX vs THW Comparison
Compare LXRX & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- THW
- Stock Information
- Founded
- LXRX 1995
- THW 2015
- Country
- LXRX United States
- THW United States
- Employees
- LXRX N/A
- THW N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- THW Finance Companies
- Sector
- LXRX Health Care
- THW Finance
- Exchange
- LXRX Nasdaq
- THW Nasdaq
- Market Cap
- LXRX 552.4M
- THW 511.8M
- IPO Year
- LXRX 2000
- THW N/A
- Fundamental
- Price
- LXRX $1.38
- THW $13.07
- Analyst Decision
- LXRX Buy
- THW
- Analyst Count
- LXRX 5
- THW 0
- Target Price
- LXRX $3.23
- THW N/A
- AVG Volume (30 Days)
- LXRX 2.4M
- THW 149.9K
- Earning Date
- LXRX 11-06-2025
- THW 01-01-0001
- Dividend Yield
- LXRX N/A
- THW 10.76%
- EPS Growth
- LXRX N/A
- THW N/A
- EPS
- LXRX N/A
- THW N/A
- Revenue
- LXRX $58,432,000.00
- THW N/A
- Revenue This Year
- LXRX $66.55
- THW N/A
- Revenue Next Year
- LXRX N/A
- THW N/A
- P/E Ratio
- LXRX N/A
- THW N/A
- Revenue Growth
- LXRX 1504.83
- THW N/A
- 52 Week Low
- LXRX $0.28
- THW $9.76
- 52 Week High
- LXRX $1.95
- THW $14.89
- Technical
- Relative Strength Index (RSI)
- LXRX 49.80
- THW 63.93
- Support Level
- LXRX $1.30
- THW $12.90
- Resistance Level
- LXRX $1.48
- THW $13.13
- Average True Range (ATR)
- LXRX 0.07
- THW 0.18
- MACD
- LXRX -0.02
- THW -0.03
- Stochastic Oscillator
- LXRX 27.77
- THW 82.61
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies engaged in the healthcare industry. The company's investment portfolio comprises investments in different sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other areas. It also male into REIT Real Estate.